3 Results for "

DSPE-PEG1000-TAASGVRSMH

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "DSPE-PEG1000-TAASGVRSMH" in MCE Product Catalog:

Cat. No.: HY-172481
Target:  

Liposome

Research Areas:  

Cancer

DSPE-PEG1000-TAASGVRSMH is a PEG compound which composed of DSPE and TAASGVRSMH. TAASGVRSMH has a strong affinity for the NG2 proteoglycan on the PC membrane. DSPE-PEG1000-TAASGVRSMH can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-P10989
CAS No.: 241478-23-9
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

NG2 binding peptide is a short peptide that specifically recognizes NG2 proteoglycan and can be obtained by phage screening technology. NG2 binding peptide interacts with NG2 binding sites to achieve precise targeting of tumor angiogenesis in vitro and in vivo. NG2 binding peptide exhibits significant homing ability in wild-type tumor-bearing mice, but has no localization effect in NG2 knockout mice. Due to the tissue specificity of NG2 expression, NG2 binding peptide can be used in scenarios such as tumor targeted therapy, drug delivery, and molecular imaging diagnosis .
loading...
    loading...
Cat. No.: HY-P11838
Research Areas:  

Cancer

DOTA-TH10 is a CSPG4-targeted probe that enables targeted enrichment in tumors with overexpressed CSPG4. 68Ga-radiolabeled DOTA-TH10 specifically binds to CSPG4, allowing visualization of CSPG4 expression. 68Ga-radiolabeled DOTA-TH10 exhibits significant tumor uptake capacity in pancreatic cancer and gastric cancer models. DOTA-TH10 can be used for research on pancreatic cancer and gastric cancer .
loading...
    loading...